Skip to content

SRPT

Sarepta Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$22.50
−2.13%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+40.9%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 29, 2026SEVERINO MICHAEL · director, officer: Chief Executive OfficerA-Award756,104$0.00
Jul 29, 2026SEVERINO MICHAEL · director, officer: Chief Executive OfficerA-Award2,224,342$18
Jun 5, 2026Nicaise Claude · directorA-Award16,875$0.00
Jun 5, 2026Wigzell Hans Lennart Rudolf · directorA-Award16,875$0.00
Jun 5, 2026Barry Richard · directorA-Award16,875$0.00
Jun 5, 2026Connelly Deirdre P · directorA-Award16,875$0.00
Jun 5, 2026BEHRENS M KATHLEEN · directorA-Award16,875$0.00
Jun 5, 2026Chambers Michael Andrew · directorA-Award16,875$0.00
Jun 5, 2026Boor Kathryn Jean · directorA-Award16,875$0.00
Jun 5, 2026Mayo Stephen · directorA-Award16,875$0.00
Mar 13, 2026Mayo Stephen · directorSale7,239$17
Mar 13, 2026Estepan Ian Michael · officer: Chief Operating OfficerF-InKind1,097$17
Mar 13, 2026Wong Ryan Ho-Yan · officer: Chief Financial OfficerF-InKind256$17
Mar 13, 2026Rodino-Klapac Louise · officer: President, R&D and Tech OpsF-InKind948$17
Mar 13, 2026Rothfuss Cristin · officer: EVP, General CounselF-InKind974$17
Mar 11, 2026Estepan Ian Michael · officer: Chief Operating OfficerF-InKind583$17
Mar 11, 2026Estepan Ian Michael · officer: Chief Operating OfficerF-InKind1,036$17
Mar 11, 2026Rodino-Klapac Louise · officer: President, R&D and Tech OpsF-InKind895$17
Mar 11, 2026Wong Ryan Ho-Yan · officer: Chief Financial OfficerF-InKind113$17
Mar 11, 2026Wong Ryan Ho-Yan · officer: Chief Financial OfficerF-InKind162$17
Mar 11, 2026Rothfuss Cristin · officer: EVP, General CounselF-InKind484$17
Mar 11, 2026Rothfuss Cristin · officer: EVP, General CounselF-InKind346$17
Mar 11, 2026Rodino-Klapac Louise · officer: President, R&D and Tech OpsF-InKind504$17
Mar 3, 2026Rodino-Klapac Louise · officer: President, R&D and Tech OpsF-InKind767$16
Mar 3, 2026Rodino-Klapac Louise · officer: President, R&D and Tech OpsM-Exempt8,125$0.00
Mar 3, 2026Rothfuss Cristin · officer: EVP, General CounselF-InKind408$16
Mar 3, 2026Wong Ryan Ho-Yan · officer: Chief Financial OfficerF-InKind450$16
Mar 3, 2026Estepan Ian Michael · officer: Chief Operating OfficerF-InKind3,301$16
Mar 3, 2026Estepan Ian Michael · officer: Chief Operating OfficerM-Exempt8,125$0.00
Mar 3, 2026Rodino-Klapac Louise · officer: President, R&D and Tech OpsF-InKind3,718$16
Institutional positioning

13F filings over the trailing two quarters

New 96Increased 208Reduced 260Sold out 63
FilerActionSharesFiled
BlackRock, Inc.Increased18,994,958Aug 7, 2026
BLACKROCK, INC.Increased14,755,277May 13, 2026
STATE STREET CORPIncreased8,916,090Aug 7, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased8,377,470Aug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position6,640,692May 8, 2026
STATE STREET CORPIncreased6,613,314May 15, 2026
AQR CAPITAL MANAGEMENT LLCReduced6,433,112May 15, 2026
TWO SIGMA INVESTMENTS, LPIncreased4,598,735Aug 14, 2026
TWO SIGMA INVESTMENTS, LPIncreased4,593,195May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased4,591,755Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position4,578,235May 15, 2026
FIRST TRUST ADVISORS LPIncreased4,365,951Aug 11, 2026
AQR CAPITAL MANAGEMENT LLCReduced4,325,689Aug 14, 2026
FIRST TRUST ADVISORS LPIncreased4,135,788May 13, 2026
RA CAPITAL MANAGEMENT, L.P.New Position3,902,596May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 29, 2026